WHO ICTRP trial
Clinical study on mitochondrial genome mutation in monitoring postoperative…
ChiCTR2500100248 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2500100248 |
|---|---|
| Public title | Clinical study on mitochondrial genome mutation in monitoring postoperative recurrence of urothelial carcinoma |
| Scientific title | Clinical study on mitochondrial genome mutation in monitoring postoperative recurrence of urothelial carcinoma |
| Primary sponsor | Shanghai General Hospital |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Diagnostic test |
| Countries | China |
| Conditions | Urothelial carcinoma |
| Interventions | Gold Standard:Pathological biopsy;Index test:Mitochondrial DNA testing |
| Registration date | Apr 7, 2025 |
| Target size | Target condition:30;Difficult condition:0 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: